Stephanie Mack

Stephanie Mack is a highly experienced scientist and project lead currently at Celdara Medical since January 2024. Previously, Stephanie served as Director of Platform at Zygosity from June 2022 to December 2023 and was a Postdoctoral Research Associate at the University of Cambridge, working on projects related to transgenic mouse models and CRISPR technology from January 2019 to May 2022. Prior academic roles include serving as a research mentor and graduate research assistant at Carnegie Mellon University, where Stephanie advised undergraduate students and taught various chemistry laboratories. Earlier research experience includes roles at Lehigh University and the Howard Hughes Medical Institute. Stephanie holds a PhD in Chemistry from Carnegie Mellon University and a BS in Pharmaceutical Chemistry from Lehigh University.